(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 3.71% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.14%.
Rxsight's revenue in 2026 is $134,479,000.On average, 12 Wall Street analysts forecast RXST's revenue for 2026 to be $5,437,664,963, with the lowest RXST revenue forecast at $5,160,355,192, and the highest RXST revenue forecast at $5,680,723,676. On average, 11 Wall Street analysts forecast RXST's revenue for 2027 to be $5,984,443,902, with the lowest RXST revenue forecast at $5,495,850,495, and the highest RXST revenue forecast at $6,512,652,990.
In 2028, RXST is forecast to generate $6,475,100,625 in revenue, with the lowest revenue forecast at $5,783,064,187 and the highest revenue forecast at $7,084,604,393.